Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amyloid Precursor Protein: A Regulatory Hub in Alzheimer's Disease
Jiang Chen, Junsheng Chen, Song Li, et al.
Aging and Disease (2023)
Open Access | Times Cited: 18

Showing 18 citing articles:

Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
Ernesto Fedele
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14499-14499
Open Access | Times Cited: 32
Recent advancement in understanding of Alzheimer's disease: Risk factors, subtypes, and drug targets and potential therapeutics
Sneh Prabha, Mohd Sajad, Gulam Mustafa Hasan, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102476-102476
Closed Access | Times Cited: 13
Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer’s disease
Jiang Chen, Junsheng Chen, Zhifeng Lei, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Intraneuronal binding of amyloid beta with reelin—Implications for the onset of Alzheimer’s disease
Asgeir Kobro‐Flatmoen, Stig W. Omholt
PLoS Computational Biology (2025) Vol. 21, Iss. 1, pp. e1012709-e1012709
Open Access
Multi-target approach to Alzheimer’s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms
Kashif Abbas, Mohd Rais Mustafa, Mudassir Alam, et al.
Neurogenetics (2025) Vol. 26, Iss. 1
Closed Access
Integration of Phytochemical Profiling and Computational Approaches to Evaluate the Neuroprotective Potential of Nardostachys jatamansi in Alzheimer's Disease
Abdul Jalil Shah, Mohammad Younis Dar, Mohd Adnan, et al.
Biotechnology Reports (2025) Vol. 45, pp. e00881-e00881
Open Access
Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer’s Disease
Éva Kiss, Stefan Kins, Karin Gorgas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4165-4165
Open Access | Times Cited: 3
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access | Times Cited: 3
Tailored Melatonin- and Donepezil-Based Hybrids Targeting Pathognomonic Changes in Alzheimer’s Disease: An In Vitro and In Vivo Investigation
Rositsa Mihaylova, Violina T. Angelova, Jana Tchekalarova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5969-5969
Open Access | Times Cited: 2
MicroRNAs regulating autophagy: opportunities in treating neurodegenerative diseases
Morvarid Mohseni, Ghazal Behzad, Arezoo Farhadi, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease
Shivani Chib, Bhaskar Jyoti Dutta, Rishabh Chalotra, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 2
Understanding the Molecular Impact of Physical Exercise on Alzheimer’s Disease
Alba Cantón-Suárez, Leticia Sánchez-Valdeón, Laura Bello-Corral, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13576-13576
Open Access | Times Cited: 2
Analysis for a model incorporating γ−secretase inhibitor to explore the mechanism of ‘Amyloid-β rise’
Yongxin Zhang, Mingyan Dong, Bai-Lian Li, et al.
Chaos Solitons & Fractals (2024) Vol. 183, pp. 114867-114867
Closed Access | Times Cited: 1
Increasing the Survival of a Neuronal Model of Alzheimer’s Disease Using Docosahexaenoic Acid, Restoring Endolysosomal Functioning by Modifying the Interactions between the Membrane Proteins C99 and Rab5
Maxime Vigier, Magalie Uriot, Fathia Djelti-Delbarba, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6816-6816
Open Access | Times Cited: 1
Influenza virus infection exacerbates gene expression related to neurocognitive dysfunction in brains of old mice
Wenxin Wu, Jeremy S. Alexander, J. Leland Booth, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Tetramethylpyrazine Nitrone (TBN) Reduces Amyloid β Deposition in Alzheimer’s Disease Models by Modulating APP Expression, BACE1 Activity, and Autophagy Pathways
Xinhua Zhou, Zeyu Zhu, Shaoming Kuang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1005-1005
Open Access
New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment
Violina T. Angelova, Boris Petrov Stoyanov, Rumyana Simeonova
Molecules (2024) Vol. 29, Iss. 22, pp. 5314-5314
Open Access
Designed Cell-Penetrating Peptide Constructs for Inhibition of Pathogenic Protein Self-Assembly
Mona Kalmouni, Yujeong Oh, Waël Alata, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1443-1443
Open Access
Page 1

Scroll to top